vs
Side-by-side financial comparison of PAMT CORP (PAMT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PAMT CORP is the larger business by last-quarter revenue ($141.3M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -15.1%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-25.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -12.0%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
PAMT vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $141.3M | $75.5M |
| Net Profit | $-29.3M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -27.0% | 22.7% |
| Net Margin | -20.7% | — |
| Revenue YoY | -15.1% | 27.7% |
| Net Profit YoY | 7.4% | — |
| EPS (diluted) | $-1.38 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $141.3M | $75.5M | ||
| Q3 25 | $150.3M | $54.5M | ||
| Q2 25 | $151.1M | $52.4M | ||
| Q1 25 | $155.3M | $46.0M | ||
| Q4 24 | $166.5M | $59.1M | ||
| Q3 24 | $182.6M | $80.5M | ||
| Q2 24 | $182.9M | $47.1M | ||
| Q1 24 | $182.6M | $43.8M |
| Q4 25 | $-29.3M | — | ||
| Q3 25 | $-5.6M | $8.8M | ||
| Q2 25 | $-9.6M | $5.9M | ||
| Q1 25 | $-8.1M | $3.0M | ||
| Q4 24 | $-31.6M | — | ||
| Q3 24 | $2.4M | $20.3M | ||
| Q2 24 | $-2.9M | $-4.5M | ||
| Q1 24 | $281.0K | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -27.0% | 22.7% | ||
| Q3 25 | -3.8% | 17.6% | ||
| Q2 25 | -7.3% | 12.7% | ||
| Q1 25 | -5.9% | 8.7% | ||
| Q4 24 | -22.6% | 22.6% | ||
| Q3 24 | 1.3% | 27.4% | ||
| Q2 24 | -0.4% | -4.6% | ||
| Q1 24 | -0.4% | -5.3% |
| Q4 25 | -20.7% | — | ||
| Q3 25 | -3.7% | 16.2% | ||
| Q2 25 | -6.4% | 11.2% | ||
| Q1 25 | -5.2% | 6.5% | ||
| Q4 24 | -19.0% | — | ||
| Q3 24 | 1.3% | 25.2% | ||
| Q2 24 | -1.6% | -9.6% | ||
| Q1 24 | 0.2% | -11.0% |
| Q4 25 | $-1.38 | $0.26 | ||
| Q3 25 | $-0.27 | $0.17 | ||
| Q2 25 | $-0.46 | $0.12 | ||
| Q1 25 | $-0.37 | $0.06 | ||
| Q4 24 | $-1.44 | $0.40 | ||
| Q3 24 | $0.11 | $0.41 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $83.7M | $97.5M |
| Total DebtLower is stronger | $333.9M | $22.7M |
| Stockholders' EquityBook value | $210.5M | $130.3M |
| Total Assets | $697.9M | $216.3M |
| Debt / EquityLower = less leverage | 1.59× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.7M | $97.5M | ||
| Q3 25 | $115.6M | $94.4M | ||
| Q2 25 | $117.3M | $96.0M | ||
| Q1 25 | $102.7M | $93.2M | ||
| Q4 24 | $110.7M | $101.0M | ||
| Q3 24 | $92.3M | $96.7M | ||
| Q2 24 | $114.0M | $96.8M | ||
| Q1 24 | $125.8M | $107.2M |
| Q4 25 | $333.9M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $325.6M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $210.5M | $130.3M | ||
| Q3 25 | $239.5M | $115.3M | ||
| Q2 25 | $244.9M | $104.7M | ||
| Q1 25 | $269.6M | $97.1M | ||
| Q4 24 | $277.5M | $92.1M | ||
| Q3 24 | $308.9M | $71.1M | ||
| Q2 24 | $306.7M | $48.5M | ||
| Q1 24 | $314.6M | $51.0M |
| Q4 25 | $697.9M | $216.3M | ||
| Q3 25 | $715.2M | $202.9M | ||
| Q2 25 | $707.9M | $194.9M | ||
| Q1 25 | $712.6M | $196.2M | ||
| Q4 24 | $741.7M | $213.3M | ||
| Q3 24 | $756.7M | $220.7M | ||
| Q2 24 | $733.5M | $205.0M | ||
| Q1 24 | $746.4M | $214.1M |
| Q4 25 | 1.59× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 1.17× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.8M | $14.4M |
| Free Cash FlowOCF − Capex | $-25.0M | $14.4M |
| FCF MarginFCF / Revenue | -17.7% | 19.1% |
| Capex IntensityCapex / Revenue | 13.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-23.4M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.8M | $14.4M | ||
| Q3 25 | $5.9M | $9.7M | ||
| Q2 25 | $12.2M | $14.1M | ||
| Q1 25 | $5.0M | $3.6M | ||
| Q4 24 | $15.2M | $15.6M | ||
| Q3 24 | $15.5M | $11.0M | ||
| Q2 24 | $18.7M | $1.0M | ||
| Q1 24 | $9.6M | $11.2M |
| Q4 25 | $-25.0M | $14.4M | ||
| Q3 25 | $2.5M | $9.7M | ||
| Q2 25 | $5.9M | $14.1M | ||
| Q1 25 | $-6.8M | $3.6M | ||
| Q4 24 | $-39.9M | $15.6M | ||
| Q3 24 | $-33.6M | $11.0M | ||
| Q2 24 | $4.1M | $1.0M | ||
| Q1 24 | $-12.2M | — |
| Q4 25 | -17.7% | 19.1% | ||
| Q3 25 | 1.7% | 17.7% | ||
| Q2 25 | 3.9% | 26.8% | ||
| Q1 25 | -4.4% | 7.7% | ||
| Q4 24 | -24.0% | 26.4% | ||
| Q3 24 | -18.4% | 13.7% | ||
| Q2 24 | 2.2% | 2.1% | ||
| Q1 24 | -6.7% | — |
| Q4 25 | 13.6% | 0.0% | ||
| Q3 25 | 2.3% | 0.0% | ||
| Q2 25 | 4.2% | 0.0% | ||
| Q1 25 | 7.6% | 0.1% | ||
| Q4 24 | 33.1% | 0.0% | ||
| Q3 24 | 26.9% | 0.0% | ||
| Q2 24 | 8.0% | 0.0% | ||
| Q1 24 | 12.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.44× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 34.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PAMT
| Freight Transportation Service | $123.1M | 87% |
| Fuel Surcharge | $18.2M | 13% |
PBYI
Segment breakdown not available.